Health Care/Hospital
Alma launches a special edition of Soprano Titanium with a breakthrough applicator to boost hair removal treatment speed
The latest edition of the flagship hair removal is recognized as the market's
fastest hair removal treatment, according to new research
CAESAREA, Israel, March 19, 2024 /PRNewswire/ -- Alma
QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services...
Abcam appoints Markus Lusser as new President
CAMBRIDGE, England, March 18, 2024 /PRNewswire/ -- Abcam today announced the
appointment ofMarkus Lusser as President.
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal
* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...
South Korean Insurtech Carrot has secured BBI (Behavior Based Insurance) solution project of Lippo General Insurance, Indonesia
First Step Towards Becoming a Global Insurtech * South Korean Insurtech, Carrot General Insurance has secured project for developing data platform that encompasses comprehensive risk assessment for policyholders to eventually launch behavior based auto insurance product in Indonesia * With it...
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time
* Revenue Up 2.5% Year-over-Year to RMB40,341 Million; Excluding COVID-19 Commercial Projects, Up 25.6% * Net Profit Attributable to the Owners of the Company[1] Increased 9.0% to RMB9,607 Million; Diluted Earnings per Share (EPS) Increased 14.9% to RMB3.24 * Adjusted Non-IFRS Net Profit Att...
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
SUNNYVALE, Calif., March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of its investigational device exemption (IDE) clinical tri...
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices
BELLEVUE, Wash., March 18, 2024 /PRNewswire/ -- Edan Instruments, Inc.
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis
SHENZHEN, China, March 18, 2024 /PRNewswire/ -- On March 18 2024, Shenzhen chipscreen biosciences Co., Ltd. (hereinafter referred to as "chipscreen biosciences", stock code: 688321. SH) announced that the Phase II clinical trial (CGZ203 study) of chiglitazar monotherapy for non-alcoholic steatoh...
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1
-- Tunlametinib is poised to be a potential best-in-class MEK inhibitor based on positive data from the pivotal Phase 2 study SHANGHAI, March 18, 2024 /PRNewswire/ -- KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule ...
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
EAST RUTHERFORD, N.J., March 18, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it is nearing the completion of a 5-year,$100-million-dollar investment strategy, one year ahead of schedule. The project, which adds mo...
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened i...
Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech
SINGAPORE, March 17, 2024 /PRNewswire/ -- Mediwave, a leading-edge HealthTech company, was recognised as a finalist at the prestigious Global Mobile Awards (GLOMO), part of the Mobile World Congress (MWC) powered by GSMA inBarcelona, Spain. This acknowledgment underscores Mediwave's exceptional c...
Peer2Gether Foundation Celebrates Milestone of Supporting 50 Orphanages and Elderly Care Facilities
Peer2Gether Foundation has been able to expand its reach and support orphanages and elderly care facilities acrossSingapore SINGAPORE, March 16, 2024 /PRNewswire/ – Peer2Gether Foundation, a non-profit organization dedicated to supporting orphanages and the elderly, is proud to announce that it ...
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland, March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Can...
/C O R R E C T I O N -- Sisram Medical Ltd/
In the news release, Sisram Medical to Report FY2023 Financial Results on March 20 and Hold a Conference Call on March 21, issued on 14-Mar-2024 by Sisram Medical Ltd over PR Newswire, we are advised by the company that regarding the time, specifically, the Israel Time, should read "2:00 p.m." ra...
Infinitus Leads in Innovation at FHE2024 with Groundbreaking Health Food Research
Demonstrating Technological Advances in Immunity-Boosting Complex Polysaccharides, the Company Sets New Standards for Functional Food Development GUANGZHOU, China, March 14, 2024 /PRNewswire/ – Infinitus (China) Company Ltd. was a participant in the 2024 Boao Food for Health Science Conference an...
Novartis expands its biopharmaceutical manufacturing site in Singapore
* Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing the soaring demand in the Asian market * Set to generate 100 high skilled employment opportunities in Singapore's life science industry SINGAPORE, March 15, 2024 /PRNewswire/ -- Novartis today...
Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
JINAN, China, March 15, 2024 /PRNewswire/ -- On 8 March local time, during the 25th European Society of Gynecological Oncology (ESGO) Conference (ESGO 2024) in Spain, Qilu Pharmaceutical unveiled the Phase II clinical trial results for iparomlimab and tuvonralimab (QL1706) in an oral presentation....
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment
SHENZHEN, China, March 15, 2024 /PRNewswire/ -- ImmVira has recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for oncolytic virus product MVR-T3011 IT (intratumoral injection) for the treatment of recurrent or metastatic head and neck squamous ...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14Animated Life in Yunnan
[Picked up by 275 media titles]
2024-04-18 14:00Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00